Bicycle Therapeutics Files For U.S. IPO

Bicycle Therapeutics (BCYC) has filed to raise gross proceeds of $86.25 million from a U.S. IPO, according to an S-1 registration statement.

The firm is developing antibody-like therapeutics for the treatment of underserved diseases.

Original source

Add comment

Please Sign in to be able to leave comments.